Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
   L01 ANTINEOPLASTIC AGENTS
     L01A ALKYLATING AGENTS
     L01B ANTIMETABOLITES
     L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
     L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
     L01E PROTEIN KINASE INHIBITORS
       L01EA BCR-ABL tyrosine kinase inhibitors [DG:DG03161]
       L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
         L01EB01 Gefitinib
         L01EB02 Erlotinib [DG:DG00711]
         L01EB03 Afatinib [DG:DG00717]
         L01EB04 Osimertinib
           D10766  Osimertinib mesylate (USAN) <JP/US>
         L01EB05 Rociletinib
         L01EB06 Olmutinib [DG:DG02916]
         L01EB07 Dacomitinib [DG:DG01793]
         L01EB08 Icotinib
       L01EC B-Raf serine-threonine kinase (BRAF) inhibitors [DG:DG03159]
       L01ED Anaplastic lymphoma kinase (ALK) inhibitors [DG:DG03136]
       L01EE Mitogen-activated protein kinase (MEK) inhibitors [DG:DG03137]
       L01EF Cyclin-dependent kinase (CDK) inhibitors [DG:DG03138]
       L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors [DG:DG03160]
       L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors [DG:DG03158]
       L01EJ Janus-associated kinase (JAK) inhibitors
       L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
       L01EL Bruton's tyrosine kinase (BTK) inhibitors [DG:DG02022]
       L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors [DG:DG03139]
       L01EX Other protein kinase inhibitors
     L01X OTHER ANTINEOPLASTIC AGENTS
   L02 ENDOCRINE THERAPY
   L03 IMMUNOSTIMULANTS
   L04 IMMUNOSUPPRESSANTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: October 21, 2021
According to WHO's ATC 2021

» Japanese version